Portland, OR, United States of America

Ronald W McClard


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 129(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald W McClard

Introduction

Ronald W McClard is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of drug targeting through his innovative inventions. His work focuses on enhancing the efficacy of drug delivery systems, particularly in the treatment of diseases such as cancer and viral infections.

Latest Patents

One of Ronald W McClard's key patents is titled "Covalent lipid-drug conjugates for drug targeting." This invention relates to a novel method of drug targeting that involves covalently binding a drug to a lipid carrier. The composition has the unique ability to enhance the rate at which an antineoplastic or antiviral drug crosses the plasma membrane and directs the drug within the cell to specific organelles. The versatility of these conjugates is further enhanced by including a spacer group between the drug and the lipid, which may modulate drug release at the target site. Ronald holds 1 patent for this groundbreaking work.

Career Highlights

Throughout his career, Ronald W McClard has been dedicated to advancing drug delivery technologies. His innovative approach to drug targeting has the potential to significantly improve treatment outcomes for patients. He works for the State of Oregon, where he continues to develop and refine his inventions.

Collaborations

Ronald has collaborated with esteemed colleagues in his field, including Milton Yatvin and David W Parks. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

In summary, Ronald W McClard is a pioneering inventor whose work in drug targeting has the potential to revolutionize the way medications are delivered within the body. His innovative patent on covalent lipid-drug conjugates exemplifies his commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…